Defibrillator is used to deliver high energy electric shock to the heart muscles and correct abnormal and life threatening heart rhythms. Defibrillator is used in treatment of ventricular fibrillation, cardiac dysrhythmias, pulse less ventricular tachycardia. Defibrillator reduces risks of developing dangerous heart rates. Implantable cardioverter defibrillator Market provides various advantages as it provides protection, prevent risk of a cardiac arrest and continuously monitors heart rhythms. The global defibrillators market is segmented based on the basis of product type, end user, and region.

Rapidly growing ageing population and increasing prevalence of cardiovascular diseases globally is expected to drive the growth of global defibrillators market over the forecast period. Technological advancements and innovation of defibrillators by manufacturer is expected to drive the global defibrillators market over the forecast period. In addition, increasing awareness regarding the use of device for several cardiac diseases is expected to boost the market growth over the forecast period.

Product type segment includes implantable cardioverter defibrillators and external defibrillator. The implantable cardioverter defibrillators contribute major market share and expected to maintain its dominance over the forecast period owing to its wide use in patients with high risk of sustained or recurrent arrhythmia.

End user segment includes hospital, prehospital, public access market, alternate care market, home healthcare. The hospital segment accounts major market share owing to the availability of implantable and external defibrillators in the hospitals.

Do Inquiry of the Report Here:

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the increasing incidence of cardiovascular diseases in the region.

Some prominent players in the global defibrillators market are Medtronic Plc., Boston Scientific Corporation, LivaNova Plc., Koninklijke Philips N.V., Zoll Medical Corporation, Defibtech, LLC., Biotronik SE & Co. KG, Schiller AG, HeartSine Technologies, LLC., and Physio-Control, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: